P reeclampsia is a multisystem disorder of pregnancy characterized by new onset of hypertension with significant proteinuria after 20 weeks' gestation. 1e7 This disorder affects 2% to 8% of pregnant women and is one of the leading causes of maternal and perinatal morbidity and mortality. Worldwide, 76,000 women and 500,000 babies die yearly from this disorder. 4,8,9 Preeclampsia causes immediate maternal adverse effects, including impairment of hepatorenal and coagulation systems. 10 If left untreated or in severe form, maternal pulmonary edema, eclampsia, brain injury, and death can occur. 11e13 Inadequate uteroplacental perfusion leads to fetal growth restriction and/or placental abruption, resulting in indicated preterm birth or stillbirth. Moreover, preeclampsia is associated with an increased risk of long-term cardiovascular and chronic diseases in both the mothers and their children from the affected pregnancy. 14 Specifically, women with preeclampsia are at elevated risk for chronic hypertension, future cardiovascular disease, stroke, metabolic syndromes, cognitive impairment, and chronic end-stage renal disease later in life. 15e22 Infants born to mothers affected by preeclampsia are also at risk of having medium-and long-term